dipivefrin has been researched along with Capsule Opacification in 1 studies
dipivefrin: used in treatment of both primary & open angle glaucoma; RN given refers to (+-)-isomer
dipivefrin : The dipivalate ester of (+-)-epinephrine (racepinephrine). A pro-drug of epinephrine, the hydrochloride is used topically as eye drops to reduce intra-ocular pressure in the treatment of open-angle glaucoma or ocular hypertension.
Capsule Opacification: Clouding or loss of transparency of the posterior lens capsule, usually following CATARACT extraction.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Auffarth, GU | 1 |
| Brézin, A | 1 |
| Lignereux, F | 1 |
| Khoramnia, R | 1 |
| Yildirim, TM | 1 |
| Kohnen, T | 1 |
| Bianco, J | 1 |
1 trial available for dipivefrin and Capsule Opacification
| Article | Year |
|---|---|
Randomized multicenter trial to assess posterior capsule opacification and glistenings in two hydrophobic acrylic intraocular lenses.
Topics: Capsule Opacification; Cataract Extraction; Humans; Lens, Crystalline; Lenses, Intraocular; Prospect | 2023 |